Alexandra Easson

Dr. Alexandra Easson


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2008 in European Journal of Cancer
Verified
Journal Article
Closed access
CRCarla Ida Ripamonti
Carla Ida Ripamonti
Alexandra EassonAlexandra Easson
Alexandra Easson
HGHans Gerdes
Hans Gerdes

1 January 2010 in International Journal of Surgery
Verified
Journal Article
Closed access
HNHesahm Najjar
Hesahm Najjar
Alexandra EassonAlexandra Easson
Alexandra Easson
The impression among Arab Physicians dealing with breast cancer is that it presents at an earlier age and at a more advanced stage as compared to western countries. However, the statistical data to support this impression is remarkably scarce. We performed a comprehensive literature review of reports of breast cancer in Arab countries. Articles were identified from Saudi Arabia, Bahrain, Qatar, Kuwait, Emirate, Oman, Yemen, Iraq, Syria, Jordan, Lebanon, Egypt, Libya, Algeria, Tunis, Morocco, and Sudan. Twenty eight articles were identified and reviewed. The average age at diagnosis of breast cancer was available in 18 articles; the average age was 48 (SD = 2.8), range 43-52, median 48.5 and mode 45 years among the 7455 patients included. The median age of diagnosis of breast cancer was available in 8 articles; here, the average age was 45.4 (SD = 4.8), range 40-54.5, median 44.5 years among the 5379 patients included. The percentage of patients that were younger than 50 years old was reported in 11 articles from 8 countries and included 5144 patients; 65.5% (SD = 11) were less than 50 years old (range 49-78%, median = 66%). In this literature review, the average age at presentation of breast cancer in Arab countries appears to be a decade earlier than in western countries. If this is true, this has important implications for screening and cancer management strategies in these countries, including the ideal age at which to begin screening. Adoption of Western guidelines "without critical amendment" in planning breast cancer programs will waste resources without achieving desired outcomes. Determination of the true frequency and age of onset of breast cancer in Arab women should be an important research priority.

1 July 2003 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
NMNeil MacDonald
Neil MacDonald
Alexandra EassonAlexandra Easson
Alexandra Easson
VMVera C Mazurak
Vera C Mazurak
GDGeoffrey P Dunn
Geoffrey P Dunn
Vickie Elaine BaracosVickie Elaine Baracos
Vickie Elaine Baracos

20 July 2007 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
DSDan Schiller
Dan Schiller
BCBernard J. Cummings
Bernard J. Cummings
SRSundeep Rai
Sundeep Rai
LLLisa W. Le
Lisa W. Le
LLLinda Last
Linda Last
CSCarol J. Swallow
Carol J. Swallow

15 November 2018 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
ATAras Toker
Aras Toker
LNLinh T. Nguyen
Linh T. Nguyen
SSSimone C. Stone
Simone C. Stone
SYS.Y. Cindy Yang
S.Y. Cindy Yang
SKSarah Rachel Katz
Sarah Rachel Katz
POPamela S. Ohashi
Pamela S. Ohashi
Purpose: Regulatory T (Treg) cells expressing the transcription factor FOXP3 are essential for the maintenance of immunologic self-tolerance but play a detrimental role in most cancers due to their ability to suppress antitumor immunity. The phenotype of human circulating Treg cells has been extensively studied, but less is known about tumor-infiltrating Treg cells. We studied the phenotype and function of tumor-infiltrating Treg cells in ovarian cancer and melanoma to identify potential Treg cell–associated molecules that can be targeted by tumor immunotherapies. Experimental Design: The phenotype of intratumoral and circulating Treg cells was analyzed by multicolor flow cytometry, mass cytometry, RNA-seq, and functional assays. Results: Treg cells isolated from ovarian tumors displayed a distinct cell surface phenotype with increased expression of a number of receptors associated with TCR engagement, including PD-1, 4-1BB, and ICOS. Higher PD-1 and 4-1BB expression was associated with increased responsiveness to further TCR stimulation and increased suppressive capacity, respectively. Transcriptomic and mass cytometry analyses revealed the presence of Treg cell subpopulations and further supported a highly activated state specifically in ovarian tumors. In comparison, Treg cells infiltrating melanomas displayed lower FOXP3, PD-1, 4-1BB, and ICOS expression and were less potent suppressors of CD8 T-cell proliferation. Conclusions: The highly activated phenotype of ovarian tumor-infiltrating Treg cells may be a key component of an immunosuppressive tumor microenvironment. Receptors that are expressed by tumor-infiltrating Treg cells could be exploited for the design of novel combination tumor immunotherapies. Clin Cancer Res; 24(22); 5685–96. ©2018 AACR.

1 November 2014 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
KHKathy Han
Kathy Han
BCBernard J. Cummings
Bernard J. Cummings
PLPatricia Lindsay
Patricia Lindsay
JSJulia Skliarenko
Julia Skliarenko
TCTim Craig
Tim Craig
JKJohn Kim
John Kim